The current price of 300347.SZ is CN¥51.61 — it has decreased by 4.20% since the previous close. Data as of Nov 6, 2026.
300347.SZ is up 6.63% over the past week, down 6.96% over the past month and down 12.06% over the past year. The price is below its 200-day moving average of CN¥52.32.
Of the 13 analysts covering Hangzhou Tigermed Consulting Co., Ltd, 1 rates it a strong buy, 6 rate it a buy, 4 rate it a hold and 2 rate it a strong sell. The overall consensus is neutral. Analyst ratings are opinions and do not guarantee future performance.
Hangzhou Tigermed Consulting Co., Ltd has a market capitalization of CN¥37.78B. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.
In its most recent quarterly report, Hangzhou Tigermed Consulting Co., Ltd posted earnings of CN¥0.1686 per share against an estimate of CN¥0.322, missing expectations by 47.64%. Upcoming reports are listed in the earnings calendar.
Hangzhou Tigermed Consulting Co., Ltd reported revenue of CN¥2.07B in its most recent quarter, which has increased by 16.43% compared with the same quarter a year earlier. Analysts had expected CN¥2.02B.
Yes. Hangzhou Tigermed Consulting Co., Ltd pays dividends annually. The latest payment of CN¥0.126 per share has a payment date of Jul 10, 2026, which corresponds to a dividend yield of 0.27%.
Companies most comparable to Hangzhou Tigermed Consulting Co., Ltd include WuXi AppTec Co., Ltd., Pharmaron Beijing Co., Ltd., Asymchem Laboratories (Tianjin) Co., Ltd. and Joinn Laboratories(China)Co.,Ltd.
In the latest trading session 300347.SZ moved between CN¥48.40 and CN¥53.69, a range of 10.25% of its current price.
Investing in stocks requires thorough research: study the company's financials, related news and technical analysis before making a decision. Technical analysis of Hangzhou Tigermed Consulting Co., Ltd shows a sell rating today and a sell rating on the weekly timeframe. Market conditions change quickly, so it is worth looking further ahead as well — the 1-month rating for Hangzhou Tigermed Consulting Co., Ltd is strong sell. Technical ratings are indicators, not investment advice.
Over the past 52 weeks 300347.SZ has traded between CN¥35.57 and CN¥67.85. The current price is 23.94% below its 52-week high.
Figures as of Nov 6, 2026. This information is provided for general purposes only and is not investment advice.